Fig. 1From: From bench to bedside: in vitro and in vivo evaluation of a neonate-focused nebulized surfactant delivery strategy(a) Scheme of the experimental setup. (b) Mass median diameter (MMD) of nebulized surfactant measured by laser diffraction under different relative humidity (RH) conditions. (c) Fine particle fraction (FPF) of nebulized surfactant under different RH conditions. (d) Mean cumulative percentage of deposited surfactant within the different setup compartments (n = 5) and cumulative percentage of deposited surfactant for individual experiments, each of them conducted with independent nebulizer units. * P vs. RH 30% < 0.01Back to article page